Details for Patent: 11,964,018
Which drugs does patent 11,964,018 protect, and when does it expire?
Patent 11,964,018 protects PEDMARK and is included in one NDA.
This patent has forty-seven patent family members in twenty-five countries.
Summary for Patent: 11,964,018
| Title: | Therapeutic uses for sodium thiosulfate formulations |
| Abstract: | Described herein is anhydrous sodium thiosulfate, methods for synthesizing anhydrous sodium thiosulfate, pharmaceutical compositions thereof, and methods of treating ototoxicity. Anhydrous sodium thiosulfate is synthesized from sodium sulfite, sulfur, and cetylpyridinium chloride. The anhydrous sodium thiosulfate is formulated into a pharmaceutical composition comprising a buffer and solvent. These compositions are useful for eliminating or reducing ototoxicity in pediatric patients receiving platinum-based chemotherapeutics. |
| Inventor(s): | Alexander Smith |
| Assignee: | Ads Pharma Consulting LLC , Avista Pharma Solutions Inc , Fennec Pharmaceuticals Inc |
| Application Number: | US17/992,715 |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for patent 11,964,018 |
|
Patent Claim Types: see list of patent claims | Use; Composition; |
Drugs Protected by US Patent 11,964,018
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Fennec Pharms Inc | PEDMARK | sodium thiosulfate | SOLUTION;INTRAVENOUS | 212937-001 | Sep 20, 2022 | RX | Yes | Yes | 11,964,018 | ⤷ Start Trial | USE OF A PHARMACEUTICAL COMPOSITION OF ABOUT 0.5M SODIUM THIOSULFATE, ABOUT 0.004M BORIC ACID, AND A PH OF BETWEEN ABOUT 6.5 AND 8.9 FOR REDUCING OTOTOXICITY IN A PEDIATRIC PATIENT RECEIVING CISPLATIN FOR THE TREATMENT OF LOCALIZED CANCER | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 11,964,018
| Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
|---|---|---|---|---|---|
| Australia | 2019299216 | ⤷ Start Trial | |||
| Australia | 2019299217 | ⤷ Start Trial | |||
| Australia | 2025204721 | ⤷ Start Trial | |||
| Brazil | 112021000021 | ⤷ Start Trial | |||
| Brazil | 112021000022 | ⤷ Start Trial | |||
| Canada | 3103982 | ⤷ Start Trial | |||
| Canada | 3103986 | ⤷ Start Trial | |||
| >Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |
